Treatment of cognitive deficits in schizophrenia

Christopher R. Bowie, Philip D Harvey

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Cognitive deficits are a core feature of schizophrenia and are a major contributor to functional disability. These impairments persist even when patients are in remission of psychotic symptoms and have, to date, eluded treatment. While some improvement is noted with existing medications, current trends in this field include studying and searching for adjunctive treatments to truly remediate cognitive dysfunction in schizophrenia. Psychosocial treatments have demonstrated some success, but the use of existing cognitive enhancers in schizophrenia treatment has provided little cognitive improvement. This paper reviews the current status of cognitive deficit treatment in schizophrenia and offers suggestions for future work.

Original languageEnglish
Pages (from-to)608-613
Number of pages6
JournalCurrent Opinion in Investigational Drugs
Volume7
Issue number7
StatePublished - Jul 1 2006
Externally publishedYes

Fingerprint

Schizophrenia
Nootropic Agents
Therapeutics

Keywords

  • Antipsychotics
  • Cognitive deficits
  • Pharmacological augmentation
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology

Cite this

Treatment of cognitive deficits in schizophrenia. / Bowie, Christopher R.; Harvey, Philip D.

In: Current Opinion in Investigational Drugs, Vol. 7, No. 7, 01.07.2006, p. 608-613.

Research output: Contribution to journalArticle

@article{cd15bfffb6314c20b39cf9816a7f152a,
title = "Treatment of cognitive deficits in schizophrenia",
abstract = "Cognitive deficits are a core feature of schizophrenia and are a major contributor to functional disability. These impairments persist even when patients are in remission of psychotic symptoms and have, to date, eluded treatment. While some improvement is noted with existing medications, current trends in this field include studying and searching for adjunctive treatments to truly remediate cognitive dysfunction in schizophrenia. Psychosocial treatments have demonstrated some success, but the use of existing cognitive enhancers in schizophrenia treatment has provided little cognitive improvement. This paper reviews the current status of cognitive deficit treatment in schizophrenia and offers suggestions for future work.",
keywords = "Antipsychotics, Cognitive deficits, Pharmacological augmentation, Schizophrenia",
author = "Bowie, {Christopher R.} and Harvey, {Philip D}",
year = "2006",
month = "7",
day = "1",
language = "English",
volume = "7",
pages = "608--613",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "7",

}

TY - JOUR

T1 - Treatment of cognitive deficits in schizophrenia

AU - Bowie, Christopher R.

AU - Harvey, Philip D

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Cognitive deficits are a core feature of schizophrenia and are a major contributor to functional disability. These impairments persist even when patients are in remission of psychotic symptoms and have, to date, eluded treatment. While some improvement is noted with existing medications, current trends in this field include studying and searching for adjunctive treatments to truly remediate cognitive dysfunction in schizophrenia. Psychosocial treatments have demonstrated some success, but the use of existing cognitive enhancers in schizophrenia treatment has provided little cognitive improvement. This paper reviews the current status of cognitive deficit treatment in schizophrenia and offers suggestions for future work.

AB - Cognitive deficits are a core feature of schizophrenia and are a major contributor to functional disability. These impairments persist even when patients are in remission of psychotic symptoms and have, to date, eluded treatment. While some improvement is noted with existing medications, current trends in this field include studying and searching for adjunctive treatments to truly remediate cognitive dysfunction in schizophrenia. Psychosocial treatments have demonstrated some success, but the use of existing cognitive enhancers in schizophrenia treatment has provided little cognitive improvement. This paper reviews the current status of cognitive deficit treatment in schizophrenia and offers suggestions for future work.

KW - Antipsychotics

KW - Cognitive deficits

KW - Pharmacological augmentation

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=33745791791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745791791&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 608

EP - 613

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 7

ER -